# Trade Mark Journal No.2025/049 5 December 2025

## WO0000001887805 (42)

Office of origin: United States of America

Date of International Registration:17 October 2025
Date of designation in the UK: 17 October 2025

International priority date claimed: 17 October 2025 (United States of America) (99449530)

Class 42
  Scientific research and development; pharmaceutical product development in the fields of oncology, immunology, inflammatory diseases, central nervous system disorders, cardiovascular diseases, bacterial and viral infectious diseases, and other human diseases, as well as diseases affecting agriculture, husbandry, and fisheries.

BALTO PHARMACEUTICALS, INC.

Representative: Danton K. Mak LEECH TISHMAN NELSON HARDIMAN, INC., 1100 Glendon Avenue, 14th Floor, Los Angeles CA 90024, UNITED STATES OF AMERICA